Herpes simplex virus type 1 (HSV-1) immediate-early (IE) proteins are required for the expression of viral early and late proteins. It has been hypothesized that host neuronal proteins regulate expression of HSV-1 IE genes that in turn control viral latency and reactivation. We investigated the ability of neuronal proteins in vivo to activate HSV-1 IE gene promoters (ICP0 and ICP27) and a late gene promoter (gC). Transgenic mice containing IE (ICP0 and ICP27) and late (gC) gene promoters of HSV-1 fused to the Escherichia coli ␤-galactosidase coding sequence were generated. Expression of the ICP0 and ICP27 reporter transgenes was present in anatomically distinct subsets of neurons in the absence of viral proteins. The anatomic locations of ␤-galactosidase-positive neurons in the brains of ICP0 and ICP27 reporter transgenic mice were similar and included cerebral cortex, lateral septal nucleus, cingulum, hippocampus, thalamus, amygdala, and vestibular nucleus. Trigeminal ganglion neurons were positive for ␤-galactosidase in adult ICP0 and ICP27 reporter transgenic mice. The ICP0 reporter transgene was differentially regulated in trigeminal ganglion neurons depending upon age. ␤-Galactosidase-labeled cells in trigeminal ganglia and cerebral cortex of ICP0 and ICP27 reporter transgenic mice were confirmed as neurons by double labeling with antineurofilament antibody. Nearly all nonneuronal cells in ICP0 and ICP27 reporter transgenic mice and all neuronal and nonneuronal cells in gC reporter transgenic mice were negative for ␤-galactosidase labeling in the absence of HSV-1. We conclude that factors in neurons are able to differentially regulate the HSV-1 IE gene promoters (ICP0 and ICP27) in transgenic mice in the absence of viral proteins. These findings are important for understanding the regulation of the latent and reactivated stages of HSV-1 infection in neurons.
Herpes simplex virus (HSV) causes significant disease in humans, including keratitis, conjunctivitis, encephalitis, and disseminated infections of the newborn (65) . Lytic infection occurs initially at peripheral sites and is followed by axonal transport of HSV to sensory ganglion neurons. Neurons undergo either lytic or latent viral infection (59, 60) . HSV type 1 (HSV-1) immediate-early (IE) genes are thought to be important in determining the outcome of infection (54) . The level of IE gene expression may play a role in cell tropism, establishment of and reactivation from latency (19, 21) , and the extent of viral replication and disease. The HSV-1 IE ICP0 protein stimulates expression of early and late viral genes (6, 16, 17, 18, 22, 23, 39, 48, 67) . ICP0 has been shown to initiate viral gene expression from a quiescent HSV-1 genome in cultured cells (25, 26, 29, 66, 68) , and it appears to play a role in reactivation of the latent HSV-1 genome from sensory ganglion neurons in vivo (7, 35) .
Many studies of the mechanism of IE gene regulation have been performed with cultured cells; however, little information exists about activation of the viral IE genes ICP0 and ICP27 in vivo in neurons. In vitro, expression of the viral IE genes has been shown to be activated by protein complexes composed of both viral and host proteins (3, 14, 24, 41, 47, 52, 58) . The viral transactivator VP16 forms a complex with the host DNA binding protein Oct-1 and host proteins including HCF to upregulate transcription of IE genes.
It has been hypothesized that regulation of viral IE genes by neuronal proteins may control latent and reactivated infections of HSV-1 (19, 21, 61) . Since HSV-1 mutants which have had the VP16 gene deleted can establish a latent infection and reactivate (57) and there is no evidence that VP16 is present in latently infected neurons, it does not appear that VP16 is involved in reactivation from latency. Rather, it appears that nonviral host proteins (neuronal) must fulfill the role of transactivating the IE promoters in the latent genome. It is possible but less likely that viral promoters other than IE promoters are the targets for reactivation of HSV-1. Latency could be maintained either by a decreased level or absence of host transcriptional activators or by an increased level or presence of host repressors of viral IE genes. Neuronal transcription factors (for example, c-Jun, JunD, and Oct-1) are differentially expressed in specific subsets of neurons (27, 28) . The level of expression of neuronal transcription factors such as c-Jun varies in neurons during different stages of development and in regenerating neurons following damage by axotomy (28) . Infection with HSV-1 induces the expression of genes encoding transcription factors in neurons (62) . A point of much importance to the previously discussed hypothesis of latent HSV-1 regulation is whether in vivo neurons have the capacity to differentially regulate viral IE gene expression (particularly that of ICP0) in the absence of viral proteins. Specifically, it is important to determine experimentally (i) whether host neuronal proteins are capable of activating HSV-1 IE genes in the absence of viral proteins, (ii) whether there are variations in the capacity of host transcriptional proteins to activate HSV-1 IE promoters (ICP0 and ICP27) in different subsets of neurons in animals, and (iii) whether changes in expression of neuronal transcription fac-tors can alter the level of activation of HSV-1 IE promoters in a specific subset of neurons in the absence of viral proteins. It would be expected that the specific array of transcriptional proteins which are available to activate expression of a viral gene would vary in different subsets of neurons and in the same neuronal subset during different stages of differentiation. Development and differentiation of neurons results in changes in expression of transcription factors (28) . Examination of different ages of neurons in reporter transgenic mice allows us a convenient test of whether specific neurons can change their capacity to activate HSV-1 IE promoters (particularly ICP0) in the absence of viral proteins.
We previously reported that transcriptional activation of the HSV-1 ICP4 promoter occurs in specific neurons in transgenic mice (43) . In order to further study the ability of neurons to activate IE genes of HSV-1, reporter transgenic mice which contain IE gene promoters (ICP0 and ICP27) and a late gene promoter (glycoprotein C [gC]) fused to the ␤-galactosidasecoding sequence were generated. We found that neurons differentially activated the ICP0 and ICP27 promoters in transgenic mice in the absence of viral proteins. The late gene (gC) promoter was not activated without virus infection in neurons. This suggests that neuronal proteins are capable of specifically regulating the HSV-1 ICP0 and ICP27 promoters. Neuronal regulation of HSV-1 IE genes such as ICP0 may be important in maintenance of latent infection and reactivation of the viral genome from latency.
MATERIALS AND METHODS
Generation and identification of transgenic mice. The promoter regulatory regions for IE genes ICP0 and ICP27 and late gene gC of HSV-1 were each fused to the bacterial ␤-galactosidase-coding sequence by using standard techniques (55) to produce reporter transgenes (Fig. 1) . For ICP0, the promoter regulatory region (nucleotides Ϫ811 through ϩ148 with respect to the transcription start site of ICP0) (37, 50, 53) was removed by NcoI-SacI digestion from the 1.6-kb BamHI-SacI fragment (46) of the BamHI SP fragment of HSV-1 (51) . The NcoI-SacI fragment was made blunt ended and ligated in the proper orientation into the pNlacF plasmid (restriction digested at the SalI site and made blunt ended). The pNlacF plasmid contains the Escherichia coli ␤-galactosidase-coding sequence and a simian virus 40 nuclear translocation signal (42) . The promoter regulatory region of the HSV-1 ICP27 gene (nucleotides Ϫ270 through ϩ55 with respect to the transcription start site of ICP27) was removed by HinFI-BamHI digestion from the BamHI B fragment of HSV-1 (37, 50, 51). The HinFI-BamHI fragment containing the ICP27 promoter was blunt ended and ligated in the proper orientation into the pNlacF vector as described above. The promoter regulatory region from the HSV-1 late gene gC (nucleotides Ϫ45 through ϩ122 with respect to the transcription start site of gC) (31, 40) was removed by NsiI-EcoRI digestion from a plasmid containing the XbaI E fragment of HSV-1 (8) . The NsiI-EcoRI fragment containing the gC promoter was made blunt ended and ligated in the proper orientation into the pNlacF vector as described above. The XbaI-HindIII fragment containing the viral promoter fused to ␤-galactosidase from each of the three final reporter transgene constructs (Fig. 1 ) was isolated and purified as previously described (43) . For each construct approximately 200 copies were injected (30, 45) into (C57BL/6xC3H) ϫ (C57BL/6xC3H) one-cell embryos. Two transgenic lines were examined in detail for the ICP0 reporter transgene, three transgenic lines were examined for the ICP27 reporter transgene, and three transgenic lines were examined for the gC reporter transgene. Transgenic lines were established from founders through brother-sister matings. For each line, heterozygous transgenic mice and their nontransgenic control littermates were used in experiments. Mice were identified as transgenic or nontransgenic for each of the three reporter transgenes by PCR of tail DNA (45) for the ␤-galactosidase sequence (43) . The primers for the ␤-galactosidase coding sequence were GCATCGAGCTGGGTAATAAGCGTTGGCAAT and GACACCAGACCAACTGGTAATGGTAGCGAC.
Analysis of transgene expression in uninfected mice. Adult mice, 8 to 10 weeks old, from each of the eight transgenic lines were euthanized, and tissues were removed and stored at Ϫ70°C. The following tissues were examined for each of four mice from each transgenic line: brain, trigeminal ganglia, spinal cord, cornea, heart, lung, liver, spleen, kidney, adrenal gland, and small intestine. Whole trigeminal ganglia, cornea, and brain (every other section of the brain) were examined for each animal. Four representative sections of all other tissues for each animal were studied. Trigeminal ganglia and eyes were fixed as whole tissues in 4% paraformaldehyde for 30 min immediately following removal from Ϫ70°C. All other tissues were sectioned at 40 m with a cryotome, adhered to glass slides, and fixed in 4% paraformaldehyde for 30 min. Tissue sections, whole eyes, and whole ganglia were washed in phosphate-buffered saline (PBS) for 5 min and incubated in substrate solution (43) for 14 to 18 h at 37°C. The substrate solution contained 20 mM potassium ferrocyanide, 20 mM potassium ferricyanide, 2 mM MgCl 2 , 1 mg of 5-bromo-4-chloro-3-indolyl-␤-D-galactosidase (XGal) per ml, 120 l of 10% Nonidet P-40, and 100 l of 1% sodium deoxycholate per 20 ml. Labeled tissue sections and whole tissues (eyes and ganglia) were washed for 5 min in PBS. Cryotome sections, trigeminal ganglia (thinly sliced with a razor blade), and corneas (removed from eyes) were mounted on glass slides, and coverslips were sealed with Permount. In order to reveal specific morphological details, representative 40-m brain sections were counterstained with 1% neutral red for 30 s and washed three times for 5 min each in PBS before coverslips were applied. Slides were examined for positively labeled cells by light microscopy. Neuroanatomical locations were assigned according to the Mouse Brain Atlas C57BL/J Coronal found at the Mouse Brain Library website (htpp: //www.nervenet.org/mbl/).
Analysis of transgene expression in virus-infected mice. Four mice from each of the eight transgenic lines (two ICP0 lines, three ICP27 lines, and three gC lines) and four nontransgenic control mice were inoculated by the corneal route with 10 7 PFU of HSV-1 strain F per eye (9, 38, 44) . Four mice from each line were mock inoculated by the corneal route of inoculation using medium containing no virus. Mice were euthanized 4 days following inoculation, and corneas and trigeminal ganglia were analyzed as described above for the presence of ␤-galactosidase-labeled cells.
Colabeling of ␤-galactosidase-positive cells for a neuron-specific marker in brain and trigeminal ganglia of ICP0 and ICP27 reporter transgenic mice. Five-millimeter coronal slices of brain and whole trigeminal ganglia were fixed in 4% paraformaldehyde for 12 h, washed in PBS for 5 min, and incubated in substrate solution containing X-Gal (as described above) for 18 to 20 h. Samples containing ␤-galactosidase-positive cells were embedded in paraffin. Xylene was replaced by Clear-rite 3 in the embedding procedure to reduce the loss of ␤-galactosidase staining from cells. Six-micrometer sections of brain or trigeminal ganglia were mounted on positively charged glass slides, and tissue sections were deparrafinized using Clear-rite 3. Immunohistochemical localization of the mid-range-molecular-weight neurofilament protein (5, 69) was carried out with a standard biotin-avidin-peroxidase assay as described previously (38, 43, 44, 45) . The primary antibody (used at a 1:40 dilution) was a mouse monoclonal antibody directed against neurofilament protein (molecular weight, 160,000) (Sigma). As a control, adjacent sections were incubated with mouse anti-bovine CD3 monoclonal antibody used at a dilution of 1:40. The antibody-biotin-avidin-horseradish peroxidase complexes were visualized by incubation of sections in diaminobenzidine. Endogenous peroxidase activity was blocked by a 30-min incubation in FIG. 1. Diagrams of the HSV-1 IE gene (ICP0 and ICP27) and late gene (gC) reporter transgenes. The ICP0 promoter DNA fragment included nucleotides Ϫ811 through ϩ148 of the ICP0 gene. The ICP27 promoter DNA fragment included nucleotides Ϫ270 through ϩ55 of the ICP27 gene. The gC promoter DNA fragment included nucleotides Ϫ45 through ϩ122 of the gC gene. These DNA fragments were each fused to the coding sequence for the ␤-galactosidase gene of E. coli.
methanol containing 3% hydrogen peroxide. Sections were washed in PBS and incubated in a serum-free protein blocker (Dako Corporation). The M.O.M. immunodetection kit (Vector Laboratories) was used according to the manufacturer's instructions to reduce the background staining associated with using mouse antibody on mouse tissue. The reaction was terminated by washing the slides in distilled water. The slides were then dehydrated, and coverslips were sealed using Permount.
Analysis of transgene expression in trigeminal ganglion neurons of newborn and adult mice. In order to determine whether neuronal differentiation might influence transcription from the ICP0 or the ICP27 promoter, trigeminal ganglia of newborn and adult mice (8 weeks old) from each of the ICP0, ICP27, and gC lines of mice were analyzed. Four-week-old mice from each of the ICP0-␤-galactosidase and ICP27-␤-galactosidase transgenic mice lines were also examined. The total number of positive neurons per mouse (two ganglia) was determined for the following number of mice in each age group of each line of reporter transgenic mice: for the 3180 line of ICP0-␤-galactosidase transgenic mice, 14 1-day-old mice, 4 4-week-old mice, and 36 8-week-old mice; for the 3054 line of ICP27-␤-galactosidase transgenic mice, 12 1-day-old mice, 10 4-week-old mice, and 28 8-week-old mice; and for the 6305 line of ICP4-␤-galactosidase transgenic mice, 7 1-day-old mice, 3 4-week-old mice, and 7 8-week-old mice. ␤-Galactosidase assays were performed as described previously. The previously described ICP4-␤-galactosidase transgenic mice (43) were included as a control. , and TgN (HSVgCRp)3wm (Tg3405)] were generated and studied in detail. All transgenic lines were screened for expression of the reporter transgene in the presence and absence of HSV-1. Mice from each of the above-described lines were inoculated via the cornea with HSV-1(F) or mock inoculated as described above. Viral infection resulted in moderate numbers of ␤-galactosidase-positive cells in the cornea and trigeminal ganglia of gC-␤-galactosidase transgenic mice (Tg3401, Tg3403, and Tg3405) ( Fig. 2A and C and Table 1 .) No ␤-galactosidaselabeled cells were detected in age-matched mock-inoculated gC-␤-galactosidase transgenic mice (Tg3401, Tg3403, and Tg3405) or in nontransgenic littermates infected with HSV-1(F) (Fig. 2B and D and Table 1 ). Virus infection of ICP0-␤-galactosidase (Tg3180 and Tg6825) and ICP27-␤-galactosidase (Tg3054, Tg3058, and Tg6818) transgenic mice resulted in a moderate number of positive cells in the corneal stroma and an increase in numbers of positive cells in trigeminal ganglia (Table 1 and results not shown). These experiments confirmed that each of the transgenes (ICP0-␤-galactosidase, ICP27-␤-galactosidase, and gC-␤-galactosidase) was appropriately expressed in the presence of viral proteins in both neuronal and nonneuronal cells. mice. The brains of uninfected adult ICP0-␤-galactosidase transgenic mice (Tg3180 and Tg6825) and ICP27-␤-galactosidase transgenic mice (Tg3054, Tg3058, and Tg6818) each contained moderate to large numbers of ␤-galactosidase-positive cells (Fig. 3A and B and 4A and B and Table 2 ). The trigeminal ganglia of uninfected adults of both lines of ICP0-␤-galactosidase transgenic mice contained low to moderate numbers of ␤-galactosidase-positive cells ( Fig. 5B and E and Table 2 ). The trigeminal ganglia of uninfected adults of two out of the three lines of ICP27-␤-galactosidase transgenic mice contained few to low numbers of ␤-galactosidase-positive cells ( Fig. 5E and Table 2 ). No ␤-galactosidase-positive cells were detected in the brains and trigeminal ganglia of uninfected gC-␤-galactosidase transgenic mice (Tg3401, Tg3403, and Tg3405) ( Fig. 3C and Fig. 4C and Table 2 ). Nonneural tissues of transgenic mice containing the ICP0-␤-galactosidase transgene, the ICP27-␤-galactosidase transgene, and the gC-␤-galactosidase transgene were negative for ␤-galactosidase labeling, with two exceptions (Table 3 ). The Tg3054 line of ICP27-␤-galactosidase transgenic mice had scattered positive cells in the renal tubular epithelium in three of the four mice examined (Table 3) , and the Tg6818 line of ICP27-␤-galactosidase mice had low numbers of positive cells in the myocardium in three of the four mice examined (Table 3 ). The ␤-galactosidase-labeled cells in the intestinal walls of ICP0-␤-galactosidase and ICP27-␤-galactosidase transgenic mice (Table 3) were neurons in the myenteric plexus. Nontransgenic littermates from the abovedescribed transgenic lines contained no positive cells in neural ( Fig. 3D and 4D and Table 2 ) or nonneural (Table 3) tissues. ICP27 and ICP0 reporter transgenes are expressed in anatomically distinct subsets of neurons in uninfected adult mice. Brains from four uninfected mice of each ICP0-␤-galactosidase transgenic mouse line (Tg3180 and Tg6825) and ICP27-␤-galactosidase transgenic mouse line (Tg3054, Tg3058, and Tg6818) were sectioned coronally and examined as described in Materials and Methods. ICP0-␤-galactosidase transgenic mice (Tg3180 and Tg6825) and ICP27-␤-galactosidase transgenic mice (Tg3054, Tg3058, and Tg6818) contained small to moderate numbers of positive cells in anatomically defined regions of gray matter in the brain which were determined to be neurons by morphological criteria. Cerebral cortex (external granular layer) (Fig. 3A and B) , cingulum, lateral septal nucleus, hippocampus, thalamus, amygdala, and vestibular nucleus ( Fig. 4A and B ) contained positive cells in ICP0-␤-galactosidase transgenic mice (Tg3180 and Tg6825) and ICP27-␤-galactosidase transgenic mice (Tg3054, Tg3058, and Tg6818). Neurons in the external granular layer of the cerebral cortex were ␤-galactosidase positive in both ICP0-␤-galactosidase and ICP27-␤-galactosidase transgenic mice ( Fig. 3A and B) , while neurons in the molecular layer and other regions of the cerebral cortex were not labeled or were labeled in much smaller numbers. The superior colliculus, purkinje cell layer of the cerebellum, and spinal cord of ICP0-␤-galactosidase transgenic mice (Tg3180 and Tg6825) contained some positive cells, while these regions were negative for ␤-galactosidase staining in ICP27-␤-galactosidase transgenic mice (Tg3054, Tg3058, and Tg6818). White matter regions of the brain, which are composed of nonneuronal cells, contained no positive cells in all transgenic mouse lines (data not shown). No ␤-galactosidase-positive cells were present in the brains of uninfected gC-␤-galactosidase transgenic mice (Tg3054, Tg3058, and Tg6818) (Fig. 3C and 4C) .
RESULTS

Generation
␤-Galactosidase-positive cells in brain and trigeminal ganglia were identified as neurons in colabeling experiments. ␤-Galactosidase-positive cells in the cerebral cortex and trigeminal ganglia of the ICP0-␤-galactosidase line Tg3180 were colabeled for neurofilament protein, a neuron-specific marker ( Fig. 6A and B) . ␤-Galactosidase-positive cells in the cerebral cortex and trigeminal ganglia of the ICP27-␤-galactosidase line Tg3054 were also colabeled for neurofilament protein (data not shown). Neurofilament staining (brown) was seen in the neuronal cytoplasm, including the cell bodies and axons, while ␤-galactosidase label (blue) was located in the nucleus (Fig. 6A  and B) . Control mouse antibody was used on adjacent sections, and no labeling for neurofilament was detected in either cerebral cortex or trigeminal ganglia (Fig. 6C and D) . As expected, ICP0  ICP27  gC  Nontransgenic  Tg3180  Tg6825  Tg3054  Tg3058  Tg6818  Tg3401  Tg3403 (Fig. 5E ). In addition, trigeminal ganglia from 4-week-old ICP0-␤-galactosidase, ICP27-␤-galactosidase, and ICP4-␤-galactosidase transgenic mice were analyzed (Fig. 5E ). Uninfected trigeminal ganglia of newborn mice containing the ICP0-␤-galactosidase reporter transgene (Tg3180), the ICP27-␤-galactosidase reporter transgene (Tg3054), and the gC-␤-galactosidase transgene (Tg3401) contained no ␤-galactosidase-labeled cells (Fig. 5A and E and data not shown) . The ICP4 promoter was activated in large numbers of trigeminal ganglion neurons of newborn ICP4-␤-galactosidase transgenic mice (Tg6305) (Fig. 5 E) . Trigeminal ganglia of the adult ICP0-␤-galactosidase transgenic mice (Tg3180) contained moderate numbers of ␤-galactosidase-positive neurons ( Fig.  5B and E) . Trigeminal ganglia of adult ICP27-␤-galactosidase transgenic mice (Tg3054) had low numbers of ␤-galactosidasepositive neurons (Fig. 5E) . Adult gC-␤-galactosidase transgenic mice (Tg3401) had no ␤-galactosidase-positive cells, and adult ICP4-␤-galactosidase control mice (Tg6305) had few to no positive cells in trigeminal ganglia (Fig. 5E and data ICP27-␤-galactosidase (Tg3054), and ICP4-␤-galactosidase (Tg6305) transgenic mice were intermediate between adult and newborn mice (Fig. 5E ). There also were no ␤-galactosidase-labeled cells in the trigeminal ganglia of newborn, 4-week-old, or adult nontransgenic control mice (Fig. 5C and D and data not shown). The differences in numbers of ␤-galactosidase-positive cells between newborn and adult ICP0-␤-galactosidase (P ϭ 0.001) and ICP4-␤-galactosidase (P ϭ 0.001) transgenic mice were significant (Fig. 5E) . The MannWhitney rank sum test was used for statistical analysis. These data demonstrate that trigeminal ganglion neurons can differentially express the IE gene (ICP0) promoter, depending upon age.
DISCUSSION
Neuronal transcription factors activate the HSV-1 ICP0 and ICP27 promoters in reporter transgenic mice in the absence of viral proteins. Activation of HSV-1 IE promoters in vivo in the absence of viral proteins is apparently a unique property of neurons. Nonneuronal cells in the nervous system and in nonneural tissues generally did not activate the ICP0 and ICP27 promoters in transgenic mice. Two exceptions were the small numbers of renal tubular epithelial cells which were labeled for ␤-galactosidase in Tg3054 mice and the cardiac myocytes which were positively labeled in Tg6818 mice. The absence of labeling of these nonneuronal cells in any of the other transgenic mouse lines suggests that these two exceptions were anomalies. Some expression of the ICP0 promoter has been previously observed in nonneuronal cells in vitro (13, 36, 49) . However, it is likely that transcriptional regulation of the ICP0 promoter in nonneuronal cells which have undergone multiplication and passage in vitro is different from regulation in the same cells in vivo. These experiments were meant to examine the regulation of the ICP0 promoter in the more relevant in vivo context. A restricted subset of neurons contain the transcription factors which are required to activate the HSV-1 ICP0 and ICP27 promoters in the absence of viral proteins. Specific anatomically defined subsets of neurons as described in Results activated the HSV-1 IE (ICP0 and ICP27) promoters in transgenic mice, while many other types of neurons did not activate these promoters.
Particularly important is the property of a specific subset of neurons to differentially regulate the ICP0 promoter depending upon changes in the neuronal environment. The transcription factors in a specific subset of neurons can be altered by changes in the neuron such as aging or differentiation (28) . Expression of the ICP0-␤-galactosidase transgene was significantly altered by aging (differentiation) in sensory ganglion neurons. The specific characteristics of sensory neuronal regulation of ICP0 contrasts sharply with those for ICP4 which were described in an earlier study (43) . Newborn ganglia did not express the ICP0 promoter, while adult ganglia expressed the promoter in approximately 250 neurons per ganglion pair. In contrast, newborn ganglia expressed the ICP4 promoter in approximately 700 neurons per ganglion pair, while adult ganglia were negative for expression of the ICP4-␤-galactosidase transgene. These results suggest that the level of activation of HSV-1 IE gene promoters can be altered by changes in the neuronal environment without any contributions from viral regulatory molecules. Further, these results suggest that the regulatory factors controlling expression of viral IE gene reporter transgenes in trigeminal ganglion neurons are specific for ICP0 and ICP4.
As stated previously, approximately 250 out of 40,000 neurons (11, 15, 56) per ganglion (0.63%) expressed ICP0-␤-galactosidase in trigeminal ganglia of adult mice. The subset of ICP0-␤-galactosidase-positive neurons probably represents a specific phenotype of neurons which are transcriptionally regulated in a manner different from that of other trigeminal ganglion neurons. Experiments to determine the identity of the ICP0-␤-galactosidase-expressing neurons in trigeminal ganglia will be performed. It appears unlikely that the subset of neurons which express the ICP0 reporter transgene would be able to harbor a latent infection with HSV-1. This will also be determined experimentally. The important point of the presently described experiments is to demonstrate that in vivo neurons are able to transcriptionally activate the ICP0 promoter in the absence of viral proteins (including VP16) and that this property can be altered by changes in the physiolog- ICP0  ICP27  gC  Nontransgenic  Tg3180  Tg6825  Tg3054  Tg3058  Tg6818  Tg3401  Tg3403  Tg3405 Cerebellum ( ICP0  ICP27  gC  Nontransgenic  Tg3180  Tg6825  Tg3054  Tg3058  Tg6818  Tg3401  Tg3403  Tg3405   Cornea  0 (2, 10, 14, 16, 22, 23, 31, 32, 34, 37, 39, 54, 64 ). Yet much valuable data about the regulation of viral genes in cultured cells has been derived from these studies. Previous studies have used reporter transgenes to study the function of viral promoters in transgenic mice (1, 4, 20, 33, 43, 63) . In addition, one study suggests that the latent HSV-1 genome is maintained in a state which is similar to that of chromosomal DNA (12) . In summary, these experiments provide evidence that HSV-1 IE promoters (ICP0 and ICP27) can be regulated in neurons of transgenic mice by neuronal transcription factors in the absence of viral proteins. Further, sensory ganglion neurons can differentially regulate the transgenic ICP0 promoter. It seems particularly significant that the IE promoters of a neurotropic virus (HSV-1) can be differentially regulated in neurons. These results have implications for understanding the regulation of the ICP0 and ICP27 promoters in neurons in the absence of viral proteins. The capacity of sensory ganglion neurons to regulate the ICP0 promoter in the absence of viral proteins suggests the possibility that ICP0 may be important in regulation of the latent HSV genome. Experiments are currently under way to examine whether changes in activation of the ICP0 promoter occur following the types of injury to sensory ganglion neurons which have been shown to reactivate HSV-1 from latency. In addition, these viral promoters may be of use for expression of proteins in specific subsets of neurons in transgenic animals or in gene therapy protocols.
